The Mason Bioengineering Alliance is a distinguished group of accomplished individuals from our biomedical and health sciences community.
The alliance supports the mission and activities of George Mason University’s Department of Bioengineering. The alliance is the critical industry and institutional advisor to the department’s activities and programs, helping to lead the definition and execution of the department’s strategic research plan including the components of education, research, commercialization, and fundraising. This Advisory Board is composed of 10 members:
Chair of Alliance: David J. Hamilton, Neuroscientist (retired)- Intelligent Mission Consulting Services (IMCS)
Charles Anamelechi, MS, PhD, Euclid Vision Group
Arun Chowla, MD
Erin Johnson, Executive Director of Operations – Vaccines Expansion, Merck & Co, Inc.
R. Prakash Kolli, CEO and Founder – Blue Point Materials Research LLC
John Newby, CEO – Virginia Bio
Avinash Patwardhan, MD, Adjunct Assistant Professor, GMU
Abhishek Rege, Vasoptic Medical, Inc.
Tara Ruttley, Blue Origin
Irving Weinberg, MD, PhD, President – Weinberg Medical Physics, Inc
______________________________________________________________________________________________
Alliance Members from 2019-2023
Jeff Arndt, Senior System Engineer – KBR
Krishna Balakrishnan, Senior Technology Transfer Manager – National Center for Advancing Translational Sciences (NCATS), NIH
Peter Basser, Senior Investigator – Intramural Research Program (IRP); NIH Head – Section on Quantitative Imaging and Tissue Sciences (SQITS), Associate Scientific Director (ASD), Division of Imaging, Behavior and Genomic Integrity (DIBGI), and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)
Robert Caldwell, President & CEO – Strategic Health Solutions LLC
Vizma Carver, Founder, and CEO – Carver Global Health Group LLC
Jeff Conroy, CEO – Embody, Inc.
John Deeken, MD, President – Inova Schar Cancer Institute, Inova Fairfax Hospital; Senior Vice President – Inova Health System; Professor of Medicine – University of Virginia
Ross Dunlap – CEO, Ceres Nanosciences
Arthur Edge, Associate Director Global Technical Operations – AstraZeneca
Stanley Thomas Fricke, Director of Medical Physics – Department of Radiology, Georgetown University
Thomas Axel Haag, Managing Partner – Linden Lake Venture Capital
Richard Hughen, CEO – Linshom Management LLC
Chris Juncosa, Life Sciences Consultant – Dalya Partners
Neal Koller, Chairman, and CEO – Alphyn Biologics LLC
Nnamdi Nwachukwu, Vice President, Regulatory Science & Quality – RRD International
Roland Probst, Founder, and Chief Innovation Officer – ACUITYnano LLC
Steven Roberts, Senior Manager, Scientific Collaborations – GSK Vaccines
Mahesh B. Shenai, Clinical Director of Inova Neurosurgery, Director of Functional and Restorative Neurosurgery – Inova Fairfax Medical Campus
Morgan K. Sisk, Simulation Software Engineer – Northrop Grumman
Michael Tarlov, Chief – Biomolecular Measurement Division, National Institute of Standards and Technology
Marinka Tellier, PhD, Director of Regulatory Affairs – Blue Lake Technology
Eric W. Vollmecke, Deputy Director, Rapid Prototyping Research Centre - George Mason University